CD24 and colorectal carcinoma: The meta-analysis of the above results shows that the expression of CD24 in CRC can reduce the overall and disease-free survival of patients with CRC and has a specific correlation with clinicopathological parameters, such as lymph node metastasis TNM stage and so on.